Esophagus News

More frequent and longer duration of gastroesophageal reflux symptoms correlated with greater risk for poor sleep quality in women, highlighting the importance of treating patients with GERD, according to data in JAMA Network Open.

Benralizumab induced histological remission at 12 weeks in more than three-fourths of patients with eosinophilic gastritis, although other biomarkers of disease persisted, according to data in The Lancet Gastroenterology & Hepatology.

Past or current use of menopausal hormone therapy is significantly associated with GERD among postmenopausal women, according to results of a systematic review and meta-analysis.

In my more than 30-year career as a registered dietitian in gastroenterology, it has been exciting to see the role of dietitians in gastrointestinal conditions become validated and expanded upon, most markedly over the past 10 years.

The impact of dietary factors on GERD symptoms can vary among individuals. While there are general dietary recommendations that can be beneficial for many people with GERD, each person may have unique trigger foods and tolerances.

Healio will present its sixth annual Disruptive Innovators Awards for gastroenterology and hepatology this fall.

Patients with all stages of Barrett’s esophagus had similar cancer worry, highlighting the need for improved health-related quality of life through education, reassurance and follow-up care, according to data in BMJ Open Gastroenterology.

WASHINGTON — A correlation between DeMeester scores and respiratory indicators approached statistical significance in patients with bronchodilator response and pathological gastroesophageal reflux disease.

Adolescents and adults experienced sustained improvements in eosinophilic esophagitis outcomes with dupilumab for up to 52 weeks, according to research presented at Digestive Disease Week 2023 in Chicago.

CHICAGO — In this Healio video, Evan S. Dellon, MD, MPH, explains that while mepolizumab outperformed placebo at 3 months, there were no additional symptom or endoscopic improvements at 6 months in patients with eosinophilic esophagitis.